Hynd

Industry News

Biotech

Pyxis Oncology nabs Pfizer spinoff founder as new CEO 2019/12/12
Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief and director.
Compass guides magic mushroom drug through early safety test 2019/12/12
A synthetic form of the active ingredient in magic mushrooms has cleared an early-phase trial. The drug, Compass Pathways’ COMP360, came through the placebo-controlled phase 1 without setting off any …
Gilead's Kite files for FDA approval of second CAR-T therapy 2019/12/12
Gilead’s Kite has filed for FDA approval of its second CAR-T cell therapy. Kite hopes to win approval for KTE-X19 in mantle cell lymphoma on the strength of midphase results linking it to a 67% comple …
Repurposing Pfizer's heart rhythm drug Tikosyn to treat PAH 2019/12/12
Pfizer’s Tikosyn (dofetilide) has been available since 1999 to treat patients with irregular heartbeats. Now, years after the drug has gone generic, scientists at Georgetown University have found a po …
Omega Funds reels in $438M for fresh round of biopharma bets 2019/12/11
Omega Funds has raised $438 million to place another round of bets on biopharma companies. The fund, Omega’s sixth, will follow the same blueprint as earlier investment vehicles, pumping money into bu …

Error: Feed has an error or is not valid

It's official: New FDA Commissioner Hahn wins Senate confirmation 2019/12/12
Stephen Hahn, an oncologist who served as chief medical officer for the MD Anderson Cancer Center, secured Senate confirmation Thursday as FDA commissioner. During the confirmation process, he told la …
ESMO I-O: BMS zooms in on squamous lung cancer patients as it dissects Opdivo-chemo combo failure 2019/12/12
As Bristol-Myers Squibb continues to search for bright spots in its eyebrow-raising Opdivo-chemo combo fail from June, it’s zeroing in on the population of squamous lung cancer patients who seemed to …
FDA promo police publicly smack Alkermes for omitting risk info from Vivitrol ad 2019/12/12
The FDA's promotional watchdog served up its most serious ad violation to Alkermes Wednesday—and it took the unusual step of announcing that violation to the world. The warning letter cited Alker …
PCI starts work on another expansion 2019/12/12
Having only just completed an expansion of its clinical supply facility in Illinois, PCI Pharma Services will now expand its solid dose facility in Wales in the U.K.
Kite Pharma, Juno duke it out in court over megamillion-dollar CAR-T patent 2019/12/12
Behind the cell and gene therapy headlines—approvals, manufacturing snafus, new data—two of the industry’s biggest players have been battling over a single CAR-T patent. Kite Pharma and its cancer med …

Error: Feed has an error or is not valid